MCCARTHY SEAN A. (President and CEO) sold 4.8% of their position (55.51K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $149.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2025ACC: 0001610717-25-000234
DirectorOfficer· President and CEO
Since Jul 2018
-55.51K
Net shares
Net seller
$149.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
150K acquired · 205.51K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
15.1%
6/13/2025
995.20K→1.15M
Common Stock
Direct
Shares
−55.51K
Price / share
$2.69
Trade value
$149.26K
% of position
4.8%
6/16/2025
1.15M→1.09M
Total
Net shares
+94.49K
Net value
-$149.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2025 | M · Option Exercise | +150K | — | — | 15.1% | 995.20K | 1.15M |
| Common Stock Direct | 6/16/2025 | S · Sale | −55.51K | $2.69 | $149.26K | 4.8% | 1.15M | 1.09M |
| Total | +94.49K | -$149.26K | ||||||
Derivative Transactions1
Performance Stock Units
Direct
Converts to
Common Stock
150K shares
Shares
−150K
Strike price
Held after
0.00
Exercisable
—
6/13/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock150K shares | 6/13/2025 | M · Option Exercise | −150K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned93.16K
Total
93.16K indirect93.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 93.16K | Indirect |
| Total | 93.16K | 93.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported